Heart Disease News and Research

Latest Heart Disease News and Research

Eat fruits and vegetables to prevent heart disease

As heart disease continues to be the leading cause of death in the United States for all adults, a new report released by the Nutrilite Health Institute, America's Phytonutrient Report: Heart Health by Color*, shows that Americans are falling short on heart-healthy phytonutrients.

17 Feb 2010

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

St. David's HealthCare and MedCath Corporation today announced an agreement for St. David's HealthCare to acquire the Heart Hospital of Austin. St. David's HealthCare is a multi-hospital regional healthcare system based in Austin, Texas.

17 Feb 2010

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.

17 Feb 2010

NCOA survey: Communication about safety of medical imaging for patients is often inadequate

Today, the National Council on Aging released the results of a national survey of older adults, caregivers and health care providers evaluating knowledge and awareness of medical imaging safety. The survey, which focused largely on electronic implantable device patients and their caregivers, reveals that communication about the safety of medical imaging for patients with these devices is often inadequate.

17 Feb 2010

SynCardia Total Artificial Heart recipient celebrates 10 years of life

On Feb. 22, Bill Wohl, a former recipient of the SynCardia temporary CardioWest™ Total Artificial Heart, will celebrate 10 years of enjoying life to the fullest with the donor heart he received at University Medical Center on Feb. 22, 2000.

17 Feb 2010

Beating animal heart created: University of Minnesota signs global license agreement with Miromatrix Medical

A major step in commercializing the groundbreaking research of Dr. Doris Taylor was achieved recently when the University of Minnesota signed an exclusive, global license agreement with Miromatrix Medical Inc. Dr. Taylor's research garnered worldwide attention in 2008 when her team announced that it had created a beating animal heart in her laboratory.

17 Feb 2010

OTRC: Secondhand smoke exposure is a serious health hazard

New research by the Oklahoma Tobacco Research Center (OTRC) shows that concentrations of secondhand tobacco smoke inhaled in smoking rooms of restaurants and bars are exceptionally high and hazardous to health.

17 Feb 2010

LUMEDX completes extensive cardiovascular PACS deployment at IHS

LUMEDX Corporation, a leading provider of vendor-agnostic, integrated medical imaging and information systems, announced the completion of an extensive cardiovascular PACS deployment at Iowa Health Systems (IHS). Working together with IHS, a team of technical and clinical experts implemented CardioPACS multi-modality imaging system at ten affiliate hospitals across Iowa and western Illinois in under six months’ time. The first site, Trinity Regional Medical Center in Fort Dodge, went live July 3, 2009; by December 16, all ten sites were using CardioPACS.

17 Feb 2010

ICAP Ocean Tomo offers Medcanica's patent portfolio for sale

ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a patent portfolio relating to a cardiothoracic surgery system owned by Medcanica, LLC. The portfolio consists of 14 U.S. issued patents, 4 non-U.S. patents, and 1 U.S. patent application.

17 Feb 2010

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

The Society for Cardiovascular Angiography and Interventions (SCAI) today announced an educational event for the public highlighting the gender and racial disparities in the prevention and treatment of cardiovascular disease. The "Know What Counts" educational program titled, "The Path to Health Care Equity: Identifying and Solving Racial, Ethnic, and Gender Disparities in Health Care in the New Century," will feature a distinguished physician panel, along with a keynote address by U.S. Senator Ben Cardin.

17 Feb 2010

Belatacept costimulation blocker can prevent rejection of new organs by the immune system

Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).

17 Feb 2010

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

Creation of a genetic risk score comprised of multiple genetic markers associated with cardiovascular disease (CVD) was not associated with significant improvement in CVD risk prediction in a study that included more than 19,000 women, according to a study in the February 17 issue of JAMA.

17 Feb 2010

Low RVEF increases risk of death in patients with systolic heart failure

New research from the University of Alabama at Birmingham (UAB) suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart.

17 Feb 2010

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

17 Feb 2010

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Seven organizations representing policy-makers from across the country have received a total of nearly $2 million in grants from the Robert Wood Johnson Foundation (RWJF) to help communities increase children's access to affordable healthy foods and opportunities for physical activity.

17 Feb 2010

Picis launches LYNX CareBridge software to help hospitals address medical necessity challenges

To admit or not to admit? That’s the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.

17 Feb 2010

Medical journal finds divide between doctors and patients on new mammogram recommendations

News outlets explore confusion about cancer screening guidelines and questions raised about the effects of high tech procedures on health care costs and quality.

17 Feb 2010

New report focuses on how to reduce and control hypertension

High blood pressure is the second leading cause of death in the United States, triggering more than one-third of heart attacks and almost half of heart failures each year even though it is relatively easy to prevent and inexpensive to treat.

17 Feb 2010

GeneNews granted second U.S. patent for Sentinel Principle technology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."

17 Feb 2010

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company’s Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.

17 Feb 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Eat fruits and vegetables to prevent heart disease

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

NCOA survey: Communication about safety of medical imaging for patients is often inadequate

SynCardia Total Artificial Heart recipient celebrates 10 years of life

Beating animal heart created: University of Minnesota signs global license agreement with Miromatrix Medical

OTRC: Secondhand smoke exposure is a serious health hazard

LUMEDX completes extensive cardiovascular PACS deployment at IHS

ICAP Ocean Tomo offers Medcanica's patent portfolio for sale

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

Belatacept costimulation blocker can prevent rejection of new organs by the immune system

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

Low RVEF increases risk of death in patients with systolic heart failure

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Picis launches LYNX CareBridge software to help hospitals address medical necessity challenges

Medical journal finds divide between doctors and patients on new mammogram recommendations

New report focuses on how to reduce and control hypertension

GeneNews granted second U.S. patent for Sentinel Principle technology

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in